Skip to main navigation Skip to search Skip to main content

Extended follow-up results beyond 2.5 years from the pivotal NHL-1 EPCORE trial: Subcutaneous epcoritamab monotherapy in patients with relapsed/refractory large B-cell lymphoma (R/R LBCL)

  • Yasmin Karimi
  • , Catherine Thieblemont
  • , Herve Ghesquieres
  • , Chan Y. Cheah
  • , Michael Roost Clausen
  • , David Cunningham
  • , Wojciech Jurczak
  • , Kim M. Linton
  • , Martin Hutchings
  • , Tycel Jovelle Phillips
  • , Umar Farooq
  • , Won Seog Kim
  • , Minh H. Dinh
  • , Jagannath Ghosh
  • , Rajash Pallai
  • , Monica Wielgos-Bonvallet
  • , Christian Eskelund
  • , Pieternella Lugtenburg
  • , Julie Vose

Research output: Contribution to journal › Meeting Abstract › peer-review

Original languageEnglish
Number of pages1
JournalJournal of Clinical Oncology
Volume42
Issue number16
Early online date29 May 2024
DOIs
Publication statusPublished - 1 Jun 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this